INR Innovative Properties Inc.

Nabis Holdings Announces Investment Into Hivemind Refinery (“HIVEMIND”) - an Established CBD Wellness Product Line

Nabis Holdings Announces Investment Into Hivemind Refinery (“HIVEMIND”) - an Established CBD Wellness Product Line

HIVEMIND CBD Line to Be Distributed Across United States & Canada

THIS NEWS RELEASE IS NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES FOR DISSEMINATION IN THE UNITED STATES

VANCOUVER, British Columbia, Jan. 28, 2019 (GLOBE NEWSWIRE) -- Innovative Properties Inc. d/b/a Nabis Holdings (CSE:NAB; OTC: INNPF; FRA:7IP) (“Nabis” or the “Company”) is pleased to announce that the Company has entered into a binding letter of intent (“LOI”) to invest in a 70% interest of Hivemind Refinery (“HIVEMIND”), an established wellness product line of CBD-based wellness products in the United States. The investment into HIVEMIND expands Nabis’ investment portfolio to CBD edibles, water, drops, lotions, and other CBD wellness products across the spectrum and will fall under the Company’s lifestyle brand. Nabis anticipates HIVEMIND will be a premium consumer CBD line to be distributed across the United States and Canada and will be focused on products utilizing locally grown premium CBD along with unique formulations and delivery systems. HIVEMIND will be catering to an exponentially growing CBD wellness segment that includes personal health, athletic line, nutraceutical, and beauty products across North America. All HIVEMIND CBD products will undergo stringent laboratory quality assurance and quality control before formulation as well as group batch testing on products before distribution.

The recent passing of Farm Bill in the U.S. presents an extraordinary opportunity for Nabis to enter the CBD industry and capitalize on the estimated US$22 billion market. "We are very excited to be investing in HIVEMIND as a key portfolio company focusing on the significant CBD market," said Shay Shnet, CEO & Director of Nabis. "The global CBD market is expanding at an exponential rate and we intend to be one of the leaders in the space focusing on premium quality CBD-based products. We will be focused on delivery systems & products for a variety of uses including soft-gel capsules, drops, lotions, disposable vape pens and rapid dissolvable strips.”

The LOI is subject to definitive documentation and the transaction is expected to close in February 2019.

About Nabis Holdings



Nabis Holdings is a Canadian investment issuer that invests in high quality cash flowing assets across multiple industries, including real property, securities, cryptocurrency, and all aspects of the U.S. and international cannabis sector. Led by two of the co-founders of MPX Bioceutical (CSE:MPX), one of the largest takeovers in the U.S. Cannabis space to date, the company has proven track record in emerging markets to create significant shareholder value. The Company is focused on investing across the entire vertically integrated aspects of the space with a focus on revenue generation, EBITDA and growth.

ON BEHALF OF THE BOARD OF DIRECTORS

“Shay Shnet”

Shay Shnet

CEO and Director

For inquiries, please contact 604-687-7130 or email .

The CSE does not accept responsibility for the adequacy or accuracy of this release.

All statements, other than statements of historical fact, included herein are forward-looking statements that involve various risks and uncertainties. There can be no assurance that such statements will prove to be accurate and actual results and future events could differ materially from those anticipated in such statements. The risks are without limitations: that the acquisitions will be completed by the Company or completed upon the terms disclosed; the price for cannabis and related products will remain consistent and the consumer demand remains strong; availability of financing to the Company to develop the retail locations; retention of key employees and management; changes in State and/or municipal regulations of retail operations and changes in government regulations generally. Important factors that could cause actual results to differ, materially from the Company’s expectations are disclosed in the Company’s documents filed from time to time with the Canadian Securities Exchange, the British Columbia Securities Commission, the Ontario Securities Commission and the Alberta Securities Commission.

EN
28/01/2019

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Innovative Properties Inc.

 PRESS RELEASE

Nabis Holdings Commences Trading on the OTCQB® Venture Market in the ...

Nabis Holdings Commences Trading on the OTCQB® Venture Market in the U.S. Nabis Changes Fiscal Year-End to December 31 VANCOUVER, British Columbia, Nov. 13, 2019 (GLOBE NEWSWIRE) -- (CSE:NAB) (OTCQB: NABIF) (FRA:A2PL) (“NabisTM” or the “Company”), a leading Canadian investment company with specialty investments in assets across multiple divisions of the cannabis sector, today announced that its common stock has been approved for trading on the OTCQB® Venture Market under the ticker symbol “NABIF,” effective as of the opening of trading today, November 13, 2019. The Company will continu...

 PRESS RELEASE

Nabis Holdings Closes Acquisition of Emerald Phoenix and Infusion Edib...

Nabis Holdings Closes Acquisition of Emerald Phoenix and Infusion Edibles in Arizona Closing of acquisition is non-dilutive as no Nabis common shares are issued VANCOUVER, British Columbia, Oct. 28, 2019 (GLOBE NEWSWIRE) -- (CSE:NAB) (OTC: NABIF) (FRA:A2PL) (“NabisTM” or the “Company”), a leading Canadian investment company with specialty investments in assets across multiple divisions of the cannabis sector, today announced that it has completed the acquisition of 100% of the membership units of Perpetual Healthcare Inc. This acquisition, previously announced on August 12, 2019 and Oc...

 PRESS RELEASE

Nabis Holdings Receives Regulatory Approval to Operate its New Assets,...

Nabis Holdings Receives Regulatory Approval to Operate its New Assets, Emerald Phoenix and Infusion Edibles in Arizona VANCOUVER, British Columbia, Oct. 16, 2019 (GLOBE NEWSWIRE) -- (CSE:NAB) (OTC: NABIF) (FRA:A2PL) (“NabisTM” or the “Company”), a leading Canadian investment company with specialty investments in assets across multiple divisions of the cannabis sector, today announced that it has received all required regulatory approvals to operate the assets of Perpetual Healthcare Inc, Emerald Phoenix, a licensed medical marijuana dispensary located in Phoenix, Arizona and Infusion Edi...

 PRESS RELEASE

Nabis Holdings Appoints Richard Dolan as Vice President of Investor Re...

Nabis Holdings Appoints Richard Dolan as Vice President of Investor Relations VANCOUVER, British Columbia, Oct. 03, 2019 (GLOBE NEWSWIRE) -- (CSE:NAB) (OTC: NABIF) (FRA: A2PL) (“NabisTM” or the “Company”), a leading Canadian investment company with specialty investments in assets across multiple divisions of the cannabis sector, today announced that it has appointed as Vice President of Investor Relations. Mr. Dolan joins Nabis bringing 27 years of experience within the wealth management realm. From building significant books of business personally to playing various and vital roles wi...

 PRESS RELEASE

Nabis Holdings Provides Shareholder Update and Reports Third Quarter 2...

Nabis Holdings Provides Shareholder Update and Reports Third Quarter 2019 Financial Results Strengthened management team with the appointment of Nicole Rusaw as Chief Financial Officer Cash and cash equivalents of CAD$20.3 million as of July 31, 2019 VANCOUVER, British Columbia, Oct. 02, 2019 (GLOBE NEWSWIRE) -- (CSE:NAB) (OTC: NABIF) (FRA: A2PL) (“Nabis™” or the “Company”), a leading Canadian investment company with specialty investments in assets across multiple divisions of the cannabis sector, reported its financial results for the third quarter ended July 31, 2019. All financial i...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch